In vivo neural stem cell imaging: Current modalities and future directions

Regenerative Medicine

Volumn 5, Issue 1, 2010, Pages 73-86

  Gera, Atul ^a   Steinberg, Gary K ^a   Guzman, Raphael ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioluminescence; Cell labeling; In vivo imaging; Magnetic resonance; MRI; Neural stem cells; Optical imaging; PET; Positron emission tomography; Quantum dots

Indexed keywords

QUANTUM DOT;

ALZHEIMER DISEASE; BIOLUMINESCENCE; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CEREBROVASCULAR DISEASE; DEMYELINATING DISEASE; GLIOMA; HUMAN; IN VIVO STUDY; MOLECULAR IMAGING; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; THERAPY EFFECT; TRAUMATIC BRAIN INJURY;

DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; NEURONS; POSITRON-EMISSION TOMOGRAPHY; STEM CELLS;

EID: 77649333547     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.79     Document Type: Review

References (91)

1. Shapiro EM, Skrtic S, Koretsky AP: Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn. Reson. Med. 53(2), 329-338 (2005).
2. Sumner JP, Shapiro EM, Maric D, Conroy R, Koretsky AP: In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: quantification of labeled cell phenotype. Neuroimage 44(3), 671-678 (2009).
3. Aime S, Carrera C, Delli Castelli D, Geninatti Crich S, Terreno E: Tunable imaging of cells labeled with MRI-PARACEST agents. Angew. Chem. Int. Ed. Engl. 44(12), 1813-1815 (2005).
4. Brekke C, Morgan SC, Lowe AS et al.: The in vitro effects of a bimodal contrast agent on cellular functions and relaxometry. NMR Biomed. 20(2), 77-89 (2007).
5. Modo M, Beech JS, Meade TJ, Williams SC, Price J: A chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke. Neuroimage 47(Suppl. 2), T133-T142 (2008).
6. Ruiz-Cabello J, Walczak P, Kedziorek DA et al.: In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles. Magn. Reson. Med. 60(6), 1506-1511 (2008).
7. Helmberger T, Semelka RC: New contrast agents for imaging the liver. Magn. Reson. Imaging Clin. N. Am. 9(4), 745-766, vi (2001).
8. Politi LS: MR-based imaging of neural stem cells. Neuroradiology 49(6), 523-534 (2007).
9. Hammoud DA, Hoffman JM, Pomper MG: Molecular neuroimaging: from conventional to emerging techniques. Radiology 245(1), 21-42 (2007).
10. Zhang SJ, Wu JC: Comparison of imaging techniques for tracking cardiac stem cell therapy. J. Nucl. Med. 48(12), 1916-1919 (2007).
11. Modo M: Understanding stem cell-mediated brain repair through neuroimaging. Curr. Stem Cell Res. Ther. 1(1), 55-63 (2006).
12. Weber R, Wegener S, Ramos-Cabrer P, Wiedermann D, Hoehn M: MRI detection of macrophage activity after experimental stroke in rats: new indicators for late appearance of vascular degradation? Magn. Reson. Med. 54(1), 59-66 (2005).
13. Ahrens ET, Flores R, Xu H, Morel PA: In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 23(8), 983-987 (2005).
14. Zhou R, Acton PD, Ferrari VA: Imaging stem cells implanted in infarcted myocardium. J. Am. Coll. Cardiol. 48(10), 2094-2106 (2006).
15. Miyoshi S, Flexman JA, Cross DJ et al.: Transfection of neuroprogenitor cells with iron nanoparticles for magnetic resonance imaging tracking: cell viability, differentiation, and intracellular localization. Mol. Imaging Biol. 7(4), 286-295 (2005).
16. Neri M, Maderna C, Cavazzin C et al.: Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking. Stem Cells 26(2), 505-516 (2008).
17. Arbab AS, Yocum GT, Kalish H et al.: Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104(4), 1217-1223 (2004).
18. Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW: Instant MR labeling of stem cells using magnetoelectroporation. Magn. Reson. Med. 54(4), 769-774 (2005).
19. Walczak P, Ruiz-Cabello J, Kedziorek DA et al.: Magnetoelectroporation: improved labeling of neural stem cells and leukocytes for cellular magnetic resonance imaging using a single FDA-approved agent. Nanomedicine 2(2), 89-94 (2006).
20. Guzman R, Uchida N, Bliss TM et al.: Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc. Natl Acad. Sci. USA 104(24), 10211-10216 (2007).
21. Walczak P, Kedziorek DA, Gilad AA, Barnett BP, Bulte JW: Applicability and limitations of MR tracking of neural stem cells with asymmetric cell division and rapid turnover: the case of the shiverer dysmyelinated mouse brain. Magn. Reson. Med. 58(2), 261-269 (2007).
22. Chen IY, Greve JM, Gheysens O et al.: Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol. Imaging Biol. 11(3), 178-187 (2009).
23. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M: Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia 7(2), 109-117 (2005).
24. Cohen B, Ziv K, Plaks V et al.: MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat. Med. 13(4), 498-503 (2007).
25. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET: A new transgene reporter for in vivo magnetic resonance imaging. Nat. Med. 11(4), 450-454 (2005).
26. Zurkiya O, Chan AW, Hu X: MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter. Magn. Reson. Med. 59(6), 1225-1231 (2008).
27. Daldrup-Link HE, Rudelius M, Piontek G et al.: Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 234(1), 197-205 (2005).
28. Heyn C, Bowen CV, Rutt BK, Foster PJ: Detection threshold of single SPIO-labeled cells with FIESTA. Magn. Reson. Med. 53(2), 312-320 (2005).
29. Heyn C, Ronald JA, Mackenzie LT et al.: In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magn. Reson. Med. 55(1), 23-29 (2006).
30. Shapiro EM, Sharer K, Skrtic S, Koretsky AP: In vivo detection of single cells by MRI. Magn. Reson. Med. 55(2), 242-249 (2006).
31. Dodd SJ, Williams M, Suhan JP, Williams DS, Koretsky AP, Ho C: Detection of single mammalian cells by high-resolution magnetic resonance imaging. Biophys. J. 76(1 Pt 1), 103-109 (1999).
32. Arbab AS, Yocum GT, Rad AM et al.: Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 18(8), 553-559 (2005).
33. Bulte JW, Kraitchman DL, Mackay AM, Pittenger MF: Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 104(10), 3410-3412; author reply 3412-3413 (2004).
34. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW: Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 17(7), 513-517 (2004).
35. Muotri AR, Nakashima K, Toni N, Sandler VM, Gage FH: Development of functional human embryonic stem cell-derived neurons in mouse brain. Proc. Natl Acad. Sci. USA 102(51), 18644-18648 (2005).
36. Uchida N, Buck DW, He D et al.: Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 97(26) 14720-14725 (2000).
37. Kelly S, Bliss TM, Shah AK et al.: Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl Acad. Sci. USA 101(32), 11839-11844 (2004).
38. Guzman R, Bliss T, De Los Angeles A, Moseley M, Palmer T, Steinberg G: Neural progenitor cells transplanted into the uninjured brain undergo targeted migration after stroke onset. J. Neurosci. Res. 86(4), 873-882 (2008).
39. Hoehn M, Kustermann E, Blunk J et al.: Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl Acad. Sci. USA 99(25), 16267-16272 (2002).
40. Modo M, Mellodew K, Cash D et al.: Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. Neuroimage 21(1), 311-317 (2004).
41. Zhang ZG, Jiang Q, Zhang R et al.: Magnetic resonance imaging and neurosphere therapy of stroke in rat. Ann. Neurol. 53(2), 259-263 (2003).
42. Song M, Kim Y, Ryu S, Song I, Kim SU, Yoon BW: MRI tracking of intravenously transplanted human neural stem cells in rat focal ischemia model. Neurosci. Res. 64(2), 235-239 (2009).
43. Walczak P, Zhang J, Gilad AA et al.: Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39(5), 1569-1574 (2008).
44. Ben-Hur T, van Heeswijk RB, Einstein O et al.: Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. Magn. Reson. Med. 57(1), 164-171 (2007).
45. Bulte JW, Zhang S, van Gelderen P et al.: Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc. Natl Acad. Sci. USA 96(26), 15256-15261 (1999).
46. Politi LS, Bacigaluppi M, Brambilla E et al.: Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis. Stem Cells 25(10), 2583-2592 (2007).
47. Aboody KS, Brown A, Rainov NG et al.: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl Acad. Sci. USA 97(23), 12846-12851 (2000).
48. Ehtesham M, Kabos P, Gutierrez MA et al.: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 62(24), 7170-7174 (2002).
49. Benedetti S, Pirola B, Pollo B et al.: Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6(4), 447-450 (2000).
50. Lee J, Elkahloun AG, Messina SA et al.: Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector. Cancer Res. 63(24), 8877-8889 (2003).
51. Noble M: Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage? Proc. Natl Acad. Sci. USA 97(23), 12393-12395 (2000).
52. Zhang Z, Jiang Q, Jiang F et al.: In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 23(1), 281-287 (2004).
53. Brekke C, Williams SC, Price J, Thorsen F, Modo M: Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model. Neuroimage 37(3), 769-782 (2007).
54. Zhu J, Zhou L, XingWu F: Tracking neural stem cells in patients with brain trauma. N. Engl. J. Med. 355(22), 2376-2378 (2006).
55. Cai W, Guzman R, Hsu AR et al.: Positron emission tomography imaging of poststroke angiogenesis. Stroke 40(1), 270-277 (2009).
56. Muramatsu S, Okuno T, Suzuki Y et al.: Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease. Synapse 63(7), 541-548 (2009).
57. Verma IM, Somia N: Gene therapy - promises, problems and prospects. Nature 389(6648), 239-242 (1997).
58. Consiglio A, Gritti A, Dolcetta D et al.: Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc. Natl Acad. Sci. USA 101(41), 14835-14840 (2004).
59. Gambhir SS, Barrio JR, Herschman HR, Phelps ME: Assays for noninvasive imaging of reporter gene expression. Nucl. Med. Biol. 26(5), 481-490 (1999).
60. Gambhir SS, Bauer E, Black ME et al.: A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc. Natl Acad. Sci. USA 97(6), 2785-2790 (2000).
61. Singer BH, Jutkiewicz EM, Fuller CL et al.: Conditional ablation and recovery of forebrain neurogenesis in the mouse. J. Comp. Neurol. 514(6), 567-582 (2009).
62. Tjuvajev JG, Doubrovin M, Akhurst T et al.: Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med. 43(8), 1072-1083 (2002).
63. Waerzeggers Y, Klein M, Miletic H et al.: Multimodal imaging of neural progenitor cell fate in rodents. Mol. Imaging 7(2), 77-91 (2008).
64. Hung SC, Deng WP, Yang WK et al.: Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin. Cancer Res. 11(21), 7749-7756 (2005).
65. Willmann JK, Paulmurugan R, Rodriguez-Porcel M et al.: Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology 252, 117-127 (2009).
66. Qiao H, Zhang H, Zheng Y et al.: Embryonic stem cell grafting in normal and infarcted myocardium: serial assessment with MR imaging and PET dual detection. Radiology 250(3), 821-829 (2009).
67. Wu JC, Chen IY, Sundaresan G et al.: Molecular imaging of cardiac cell transplantation in living animals using optical bioluminescence and positron emission tomography. Circulation 108(11), 1302-1305 (2003).
68. Miletic H, Fischer Y, Litwak S et al.: Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol. Ther. 15(7), 1373-1381 (2007).
69. Lappalainen RS, Narkilahti S, Huhtala T et al.: The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci. Lett. 440(3), 246-250 (2008).
70. Sutton EJ, Henning TD, Pichler BJ, Bremer C, Daldrup-Link HE: Cell tracking with optical imaging. Eur. Radiol. 18(10), 2021-2032 (2008).
71. Boddington S, Henning TD, Sutton EJ, Daldrup-Link HE: Labeling stem cells with fluorescent dyes for non-invasive detection with optical imaging. J. Vis. Exp. 14, 686 (2008).
72. Tung CH: Fluorescent peptide probes for in vivo diagnostic imaging. Biopolymers 76(5), 391-403 (2004).
73. Chen X, Conti PS, Moats RA: In vivo near-infrared fluorescence imaging of integrin avb3 in brain tumor xenografts. Cancer Res. 64(21), 8009-8014 (2004).
74. Ntziachristos V, Bremer C, Weissleder R: Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol. 13(1), 195-208 (2003).
75. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM: Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 21(1), 47-51 (2003).
76. Jaiswal JK, Simon SM: Imaging single events at the cell membrane. Nat. Chem. Biol. 3(2), 92-98 (2007).
77. Sekar RB, Periasamy A: Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol. 160(5), 629-633 (2003).
78. Warshaw DM, Kennedy GG, Work SS, Krementsova EB, Beck S, Trybus KM: Differential labeling of myosin V heads with quantum dots allows direct visualization of hand-over-hand processivity. Biophys. J. 88(5), L30-L32 (2005).
79. Clapp AR, Medintz IL, Mattoussi H: Forster resonance energy transfer investigations using quantum-dot fluorophores. Chemphyschem 7(1), 47-57 (2006).
80. Michalet X, Pinaud FF, Bentolila LA et al.: Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307(5709), 538-544 (2005).
81. Jaiswal JK, Goldman ER, Mattoussi H, Simon SM: Use of quantum dots for live cell imaging. Nat. Methods 1(1), 73-78 (2004).
82. Slotkin JR, Chakrabarti L, Dai HN et al.: In vivo quantum dot labeling of mammalian stem and progenitor cells. Dev. Dyn. 236(12), 3393-3401 (2007).
83. Shah K, Hingtgen S, Kasmieh R et al.: Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J. Neurosci. 28(17), 4406-4413 (2008).
84. Kim DE, Schellingerhout D, Ishii K, Shah K, Weissleder R: Imaging of stem cell recruitment to ischemic infarcts in a murine model. Stroke 35(4), 952-957 (2004).
85. Kim DE, Tsuji K, Kim YR et al.: Neural stem cell transplant survival in brains of mice: assessing the effect of immunity and ischemia by using real-time bioluminescent imaging. Radiology 241(3), 822-830 (2006).
86. Daadi MM, Li Z, Arac A et al.: Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol. Ther. 17(7), 1282-1291 (2009).
87. Liu J, Cheng EC, Long RC Jr et al.: Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng. Part C Methods (2009) (Epub ahead of print).
88. Doubrovin M, Ponomarev V, Serganova I et al.: Development of a new reporter gene system - dsRed/xanthine phosphoribosyltransferase-xanthine for molecular imaging of processes behind the intact blood-brain barrier. Mol. Imaging 2(2), 93-112 (2003).
89. Farhadi MR, Capelle HH, Erber R, Ullrich A, Vajkoczy P: Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas. J. Neurosurg. 102(2), 363-370 (2005).
90. Mempel TR, Scimone ML, Mora JR, von Andrian UH: In vivo imaging of leukocyte trafficking in blood vessels and tissues. Curr. Opin. Immunol. 16(4), 406-417 (2004).
91. Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK: Intravascular cell replacement therapy for stroke. Neurosurg. Focus 24(3-4), E15 (2008).